203 related articles for article (PubMed ID: 14675586)
1. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy.
Isenbarger DW; Kent SM; O'Malley PG
Am J Cardiol; 2003 Dec; 92(12):1454-8. PubMed ID: 14675586
[TBL] [Abstract][Full Text] [Related]
2. Contrast-induced Nephropathy: Essentials and Concerns.
Samadian F; Dalili N; Mahmoudieh L; Ziaei S
Iran J Kidney Dis; 2018 May; 12(3):135-141. PubMed ID: 29891742
[TBL] [Abstract][Full Text] [Related]
3. Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis.
Misra D; Leibowitz K; Gowda RM; Shapiro M; Khan IA
Clin Cardiol; 2004 Nov; 27(11):607-10. PubMed ID: 15562929
[TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury: Antioxidants do not PRESERVE kidney function after contrast exposure.
Solomon R
Nat Rev Nephrol; 2018 Mar; 14(3):148-149. PubMed ID: 29355174
[No Abstract] [Full Text] [Related]
5. The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials.
Wu MY; Hsiang HF; Wong CS; Yao MS; Li YW; Hsiang CY; Bai CH; Hsu YH; Lin YF; Tam KW
Int Urol Nephrol; 2013 Oct; 45(5):1309-18. PubMed ID: 23283594
[TBL] [Abstract][Full Text] [Related]
6. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials.
Alonso A; Lau J; Jaber BL; Weintraub A; Sarnak MJ
Am J Kidney Dis; 2004 Jan; 43(1):1-9. PubMed ID: 14712421
[TBL] [Abstract][Full Text] [Related]
7. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
[TBL] [Abstract][Full Text] [Related]
8. Role of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
Brophy DF
Ann Pharmacother; 2002 Sep; 36(9):1466-70. PubMed ID: 12196069
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis.
Feng Y; Huang X; Li L; Chen Z
Nephrology (Carlton); 2018 Jun; 23(6):530-538. PubMed ID: 28452187
[TBL] [Abstract][Full Text] [Related]
10. Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study.
Moore NN; Lapsley M; Norden AG; Firth JD; Gaunt ME; Varty K; Boyle JR
J Endovasc Ther; 2006 Oct; 13(5):660-6. PubMed ID: 17042662
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.
Reinecke H; Fobker M; Wellmann J; Becke B; Fleiter J; Heitmeyer C; Breithardt G; Hense HW; Schaefer RM
Clin Res Cardiol; 2007 Mar; 96(3):130-9. PubMed ID: 17180572
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
Kelly AM; Dwamena B; Cronin P; Bernstein SJ; Carlos RC
Ann Intern Med; 2008 Feb; 148(4):284-94. PubMed ID: 18283206
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study.
Albabtain MA; Almasood A; Alshurafah H; Alamri H; Tamim H
J Interv Cardiol; 2013 Feb; 26(1):90-6. PubMed ID: 22994682
[TBL] [Abstract][Full Text] [Related]
15. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
ACT Investigators
Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
[TBL] [Abstract][Full Text] [Related]
16. Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.
Dai B; Liu Y; Fu L; Li Y; Zhang J; Mei C
Am J Kidney Dis; 2012 Sep; 60(3):360-70. PubMed ID: 22516682
[TBL] [Abstract][Full Text] [Related]
17. Nephrotoxicity of contrast media and protective effects of acetylcysteine.
Briguori C; Quintavalle C; De Micco F; Condorelli G
Arch Toxicol; 2011 Mar; 85(3):165-73. PubMed ID: 21140133
[TBL] [Abstract][Full Text] [Related]
18. [Value of N-acetylcysteine to prevent nephrotoxicity from iodinated contrast agents].
Deray G
J Radiol; 2004 Jun; 85(6 Pt 1):725-7. PubMed ID: 15243372
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Zhao SJ; Zhong ZS; Qi GX; Tian W
Int J Cardiol; 2016 Oct; 221():251-9. PubMed ID: 27404685
[TBL] [Abstract][Full Text] [Related]
20. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.
Rashid ST; Salman M; Myint F; Baker DM; Agarwal S; Sweny P; Hamilton G
J Vasc Surg; 2004 Dec; 40(6):1136-41. PubMed ID: 15622367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
